Humankind Investments LLC Royalty Pharma PLC Transaction History

Humankind Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$32.77 - $39.4 $31,655 - $38,060	966 Added 13.42%	8,162 $294,000
Q4 2022 Jan 26, 2023	BUY	$39.17 - $44.04 $9,165 - $10,305	234 Added 3.36%	7,196 $0
Q3 2022 Nov 09, 2022	BUY	$39.88 - $44.65 $18,344 - $20,539	460 Added 7.07%	6,962 $280,000
Q2 2022 Aug 05, 2022	SELL	$37.53 - $44.22 $6,905 - $8,136	-184 Reduced 2.75%	6,502 $273,000
Q1 2022 May 09, 2022	BUY	$37.46 - $42.44 $21,127 - $23,936	564 Added 9.21%	6,686 $260,000
Q4 2021 Mar 21, 2022	BUY	$35.17 - $42.48 $9,460 - $11,427	269 Added 4.6%	6,122 $244,000
Q3 2021 Mar 21, 2022	BUY	$36.14 - $42.24 $211,527 - $247,230	5,853 New	5,853 $212,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Humankind Investments LLC with notifications on news.